Arbutus Biopharma Corporation (ABUS) gained 6.69% or 0.42 to $6.78. It is about 152801 shares traded, which is 93.02% compare to the average total volume 164260. The market cap of ABUS is $373.76 million. The year to date change is 23.21%. The 52 week price range is from $3.2 to $8.25. Price of ABUS have changed 6.72% during last week. It have changed -1.55% over last month, 20.95% over last 3 months, 42.70% over last 6 months and 84.06% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ABUS is 5.82. It is -14.16% below current price. The 200-day Moving Averages for ABUS is 5.60. It is -17.40% below current price. The 52-week High is 8.25. It is 21.68% from the current price. The 52-week Low is 3.2. It is -52.80% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of ABUS is 4.61 on 2018-05-31. Short % to float is 1.26%. There are some statistics of ABUS. It is has market cap $373.76 million. The share outstanding is 55.17 million. The average volume is 164260. The revenue is 7.93M. The gross profit is -23051000. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ABUS is -51.95%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ABUS is -29.80%.